Vistagen Therapeutics, Inc.
VTGN
Revenue
176.00k
▼-4.00k▼-2.22%
3 Months ChangeAssets
113.55M
▼-10.11M▼-8.17%
3 Months ChangeLiabilities
8.75M
▼-622.00k▼-6.64%
3 Months ChangeFree Cash Flow
-16.14M
▼-9.82M▼-155.32%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-23
Form 8-K
ID: 0001411685-24-000042
2024-08-28
Form 8-K
ID: 0001437749-24-027943
2024-08-13
Form 8-K
ID: 0001411685-24-000039
2024-08-13
Form 10-Q
ID: 0001411685-24-000037
2024-07-12
Form 8-K
ID: 0001437749-24-022667
2024-07-10
Form 8-K
ID: 0001437749-24-022484
2024-06-28
Form 8-K
ID: 0001437749-24-021626
2024-06-11
Form 8-K
ID: 0001411685-24-000023
2024-05-31
Form 8-K
ID: 0001437749-24-018902
2024-05-24
Form 8-K
ID: 0001437749-24-018214